HALIFAX, Aug. 5 /CNW/ - MedMira Inc., (“MedMira”) (TSX Venture: MIR, NASDAQ: MMIRF), a developer and marketer of rapid diagnostics, announced today that it has expanded its global distribution network into Southeast Asia, where the Company’s MiraWell(R) Rapid HIV Test (MiraWell HIV) will soon be available to healthcare providers and their patients.
